{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:47:58Z","timestamp":1791946078790,"version":"4.3.4"},"reference-count":144,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>(1) Background: Vitiligo is an autoimmune skin disorder characterized by melanocyte destruction. Despite metabolic disturbances and oxidative stress also playing a key role in its pathogenesis, accumulating evidence highlights a prominent role for cytokine dysregulation. (2) Methods: A systematic search was conducted to identify meta-analyses published in the last decade that investigated cytokine involvement in vitiligo. (3) Results: Based on predefined inclusion criteria, nine meta-analyses were retrieved and reviewed. The findings confirm a central role for interferon-gamma (IFN-\u03b3) in vitiligo pathogenesis, although recent meta-analyses suggest that IFN-\u03b3 gene polymorphisms are more broadly associated with autoimmunity rather than being vitiligo-specific. Elevated interleukin-17 (IL-17) levels have been consistently reported in vitiligo patients, supporting its contribution to immune-mediated melanocyte destruction. Regulatory T cell dysfunction appears to play a crucial role in disease progression. Additionally, TNF-\u03b1-308 G\/A polymorphism has been linked to a genetic susceptibility to vitiligo, particularly in specific populations, reinforcing the role of TNF-\u03b1 in immune dysregulation. Lastly, chemokines involved in immune cell recruitment to melanocytes further illustrate the complex inflammatory network underlying the disease. (4) Conclusions: This systematic review consolidates evidence from a decade of meta-analyses, underscoring the significance of cytokine dysregulation in vitiligo and highlighting potential therapeutic targets.<\/jats:p>","DOI":"10.3390\/life15050684","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:43:37Z","timestamp":1745379817000},"page":"684","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comprehensive Overview of Cytokine Interplay in Vitiligo: A Decade of Meta-Analyses Systematically Reviewed"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-7769","authenticated-orcid":false,"given":"Alessia","family":"Paganelli","sequence":"first","affiliation":[{"name":"Dermatology Unit, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), via dei Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-2485","authenticated-orcid":false,"given":"Cristina","family":"Cristofoletti","sequence":"additional","affiliation":[{"name":"Clinical Trial Center, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-941X","authenticated-orcid":false,"given":"Francesco","family":"Moro","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), via dei Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Corrente","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), via dei Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Colonna","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), via dei Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-3262","authenticated-orcid":false,"given":"Emanuele","family":"Scala","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Istituto Dermopatico dell\u2032Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), via dei Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: A Comprehensive Overview Part I. Introduction, Epidemiology, Quality of Life, Diagnosis, Differential Diagnosis, Associations, Histopathology, Etiology, and Work-Up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet Lond. Engl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.25259\/CSDM_168_2023","article-title":"Exploring the Spectrum of Vitiligo: Clinical and Demographic Perspectives\u2014A Cross-Sectional Study","volume":"4","author":"Vedamurthy","year":"2024","journal-title":"Cosmoderma"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment. Cell Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kussainova, A., Kassym, L., Akhmetova, A., Glushkova, N., Sabirov, U., Adilgozhina, S., Tuleutayeva, R., and Semenova, Y. (2020). Vitiligo and Anxiety: A Systematic Review and Meta-Analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241445"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","article-title":"The Genetic Basis of Vitiligo","volume":"141","author":"Spritz","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/jdv.14739","article-title":"The Prevalence and Odds of Depression in Patients with Vitiligo: A Meta-Analysis","volume":"32","author":"Wang","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"D\u2019Arino, A., Picardo, M., Truglio, M., Pacifico, A., and Iacovelli, P. (2021). Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168820"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jid.2022.10.021","article-title":"Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis","volume":"143","author":"Lee","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/ijd.14055","article-title":"Comorbidities in Vitiligo: Comprehensive Review","volume":"57","author":"Dahir","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2023.06.016","article-title":"Vulvar Lichen Sclerosus and Vitiligo: Overlap and Clinical Features","volume":"89","author":"Esse","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","first-page":"218","article-title":"Association between vitiligo and metabolic syndrome: A systematic review and meta-analysis","volume":"20","author":"Chuang","year":"2022","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_14","first-page":"629","article-title":"Association between vitiligo and relevant components of metabolic syndrome: A systematic review and meta-analysis","volume":"20","author":"Kang","year":"2022","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2326297","DOI":"10.1080\/07853890.2024.2326297","article-title":"Risk Factors for Cardiovascular Diseases in Patients with Vitiligo: An Analysis of Current Evidence","volume":"56","author":"Liang","year":"2024","journal-title":"Ann. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/pcmr.12941","article-title":"Support for Increased Cardiovascular Risk in Non-Segmental Vitiligo among Egyptians: A Hospital-Based, Case-Control Study","volume":"34","author":"Azzazi","year":"2021","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100981","DOI":"10.1016\/j.arr.2019.100981","article-title":"Premature Cell Senescence in Human Skin: Dual Face in Chronic Acquired Pigmentary Disorders","volume":"57","author":"Bellei","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Papaccio, F., Ottaviani, M., Truglio, M., D\u2019Arino, A., Caputo, S., Pacifico, A., Iacovelli, P., Di Nardo, A., Picardo, M., and Bellei, B. (2024). Markers of Metabolic Abnormalities in Vitiligo Patients. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810201"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chang, W.-L., and Ko, C.-H. (2023). The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications. Cells, 12.","DOI":"10.3390\/cells12060936"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A Review and a New Hypothesis for Non-Immunological Pathogenetic Mechanisms in Vitiligo","volume":"19","author":"Picardo","year":"2006","journal-title":"Pigment. Cell Res."},{"key":"ref_21","first-page":"e208","article-title":"Interleukin-17 Level in Patients with Vitiligo: A Systematic Review and Meta-Analysis","volume":"61","author":"Acharya","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-Analysis of Alterations in Regulatory T Cells\u2019 Frequency and Suppressive Capacity in Patients with Vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/ijd.12866","article-title":"The Association Between Tumor Necrosis Factor-\u03b1-308 G\/A Polymorphism and Risk for Vitiligo: A Meta-Analysis","volume":"54","author":"Wu","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4238\/2015.May.25.6","article-title":"Associations between TNF-\u03b1 Polymorphisms and Susceptibility to Rheumatoid Arthritis and Vitiligo: A Meta-Analysis","volume":"14","author":"Lee","year":"2015","journal-title":"Genet. Mol. Res. GMR"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.4238\/2015.December.16.30","article-title":"Meta-Analysis of the TNF-\u03b1-308G\/A Polymorphism and Vitiligo Risk","volume":"14","author":"Nie","year":"2015","journal-title":"Genet. Mol. Res. GMR"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000536480","article-title":"Identification of TNF-\u03b1 as Major Susceptible Risk Locus for Vitiligo: A Systematic Review and Meta-Analysis Study in the Asian Population","volume":"240","author":"Dutta","year":"2024","journal-title":"Dermatol. Basel Switz."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"146027","DOI":"10.1016\/j.gene.2021.146027","article-title":"Meta-Analysis for Association of TNFA-308(G > A) SNP with Vitiligo Susceptibility","volume":"809","author":"Giri","year":"2022","journal-title":"Gene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/0961203315624557","article-title":"Association between Interferon- \u03b3 +874 T\/A Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-Analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Speeckaert, R., Belpaire, A., Speeckaert, M.M., and van Geel, N. (2023). A Meta-Analysis of Chemokines in Vitiligo: Recruiting Immune Cells Towards Melanocytes. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1112811"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","article-title":"CD4 T Cell-Dependent Autoimmunity against a Melanocyte Neoantigen Induces Spontaneous Vitiligo and Depends upon Fas-Fas Ligand Interactions","volume":"177","author":"Lambe","year":"2006","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","article-title":"Targeting Interferon-\u03b3 in Hyperinflammation: Opportunities and Challenges","volume":"17","author":"Prencipe","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.ymthe.2022.04.019","article-title":"RNAi-Based Modulation of IFN-\u03b3 Signaling in Skin","volume":"30","author":"Tang","year":"2022","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liu, B., Shen, J., Li, J., Tian, B., Zhou, B., Gui, J., Li, Z., Zhang, Y., Hu, W., and Li, Q. (2025). Candidate Approaches for Predicting Vitiligo Recurrence: An Effective Model and Biomarkers. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1468665"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12949","article-title":"An Update on Vitiligo Pathogenesis","volume":"34","author":"Seneschal","year":"2021","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","article-title":"Interferon-Gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2250281","DOI":"10.1002\/eji.202250281","article-title":"The IFN-\u03b3-CXCL9\/CXCL10-CXCR3 Axis in Vitiligo: Pathological Mechanism and Treatment","volume":"54","author":"Liu","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"ref_37","first-page":"3111","article-title":"IFN-\u03b3 Induces Apoptosis in Human Melanocytes by Activating the JAK1\/STAT1 Signaling Pathway","volume":"22","author":"Su","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/pcmr.13037","article-title":"The Delicate Relation Between Melanocytes and Skin Immunity: A Game of Hide and Seek","volume":"35","author":"Speeckaert","year":"2022","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of Type-I- and Type-II-Interferon-Mediated Signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Qi, F., Liu, F., and Gao, L. (2021). Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.790125"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15593258221105370","DOI":"10.1177\/15593258221105370","article-title":"Baricitinib Is Effective in Treating Progressing Vitiligo in Vivo and In Vitro","volume":"20","author":"Dong","year":"2022","journal-title":"Dose Response"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdermsci.2023.12.008","article-title":"JAK Inhibitors for the Treatment of Vitiligo","volume":"113","author":"Inoue","year":"2024","journal-title":"J. Dermatol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","article-title":"Efficacy and Safety of Oral Ritlecitinib for the Treatment of Active Nonsegmental Vitiligo: A Randomized Phase 2b Clinical Trial","volume":"88","author":"Ezzedine","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/CCID.S396430","article-title":"Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy","volume":"16","author":"Li","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","article-title":"Repigmentation in Vitiligo Using the Janus Kinase Inhibitor Tofacitinib May Require Concomitant Light Exposure","volume":"77","author":"Liu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK Inhibitors in Dermatology: The Promise of a New Drug Class","volume":"76","author":"Damsky","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jdv.14695","article-title":"Efficacy and Safety of Tofacitinib for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"32","author":"Kuo","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0006-291X(81)80248-3","article-title":"Interferon Inhibits Melanogenesis in B-16 Mouse Melanoma Cells","volume":"100","author":"Fisher","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1248\/bpb.b15-00914","article-title":"Interferon-\u03b3 Attenuates 5-Hydroxytryptamine-Induced Melanogenesis in Primary Melanocyte","volume":"39","author":"Zhou","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ijd.ijd_27_22","article-title":"A Cross-Sectional Study of the Levels of Cytokines IL-6, TNF-\u03b1, and IFN-\u03b3 in Blood and Skin (Lesional and Uninvolved) of Vitiligo Patients and Their Possible Role as Biomarkers","volume":"68","author":"De","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-Alpha, and IFN-Gamma Release by Peripheral Mononuclear Cells in Patients with Active Vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant Role of Innate Pro-Inflammatory Cytokines in Vitiligo Disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/exd.14053","article-title":"Fas-FasL Interaction in Cytotoxic T Cell-Mediated Vitiligo: The Role of Lesional Expression of Tumor Necrosis Factor-\u03b1 and Interferon-\u03b3 in Fas-Mediated Melanocyte Apoptosis","volume":"29","author":"Jimbo","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jid.2017.11.012","article-title":"Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study","volume":"138","author":"Bae","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of Interferon-Gamma Genetic Variants and Intercellular Adhesion Molecule-1 in Onset and Progression of Generalized Vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_56","first-page":"343","article-title":"Interfering with the IFN-\u03b3\/CXCL10 Pathway to Develop New Targeted Treatments for Vitiligo","volume":"3","author":"Rashighi","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_57","first-page":"208","article-title":"Polymorphisms in T Helper 1 Proinflammatory Cytokine Genes and the Risk of Psoriasis in a South Indian Tamil Cohort","volume":"15","author":"Indhumathi","year":"2017","journal-title":"J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG"},{"key":"ref_58","first-page":"52","article-title":"IFN-Gamma Promoter Gene Polymorphism in Psoriasis Vulgaris","volume":"13","author":"Baran","year":"2008","journal-title":"Biomark. Biochem. Indic. Expo. Response Susceptibility Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","article-title":"Association Between Psoriasis and Vitiligo: A Systematic Review and Meta-Analysis","volume":"20","author":"Yen","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in Vitiligo-Associated Multiple Autoimmune Disease","volume":"356","author":"Jin","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/exd.12049","article-title":"Genetic Support for the Role of the NLRP3 Inflammasome in Psoriasis Susceptibility","volume":"21","author":"Ekman","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhu, K.-J., Lv, Y.-M., Yin, X.-Y., Wang, Z.-X., Sun, L.-D., He, S.-M., Cheng, H., Hu, D.-Y., Zhang, Z., and Li, Y. (2011). Psoriasis Regression Analysis of MHC Loci Identifies Shared Genetic Variants with Vitiligo. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023089"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","article-title":"Concomitant Vitiligo and Psoriasis in a Patient Treated with Interferon Alfa-2a for Chronic Hepatitis B Infection","volume":"21","author":"Durusoy","year":"2004","journal-title":"Pediatr. Dermatol."},{"key":"ref_64","unstructured":"Hsueh, Y.-C. (2022). The Development of a Skin-Targeted Interferon-Gamma-Neutralizing Bispecific Antibody for Vitiligo Treatment. [Ph.D. Thesis, UMass Chan Medical School]."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2023.04.006","article-title":"Targeting the Elevated IFN-\u03b3 in Vitiligo Patients by Human Anti- IFN-\u03b3 Monoclonal Antibody Hampers Direct Cytotoxicity in Melanocyte","volume":"110","author":"Ng","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Sokol, C.L., and Luster, A.D. (2015). The Chemokine System in Innate Immunity. Cold Spring Harb. Perspect. Biol., 7.","DOI":"10.1101\/cshperspect.a016303"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"McCully, M.L., and Moser, B. (2011). The Human Cutaneous Chemokine System. Front. Immunol., 2.","DOI":"10.3389\/fimmu.2011.00033"},{"key":"ref_68","first-page":"27","article-title":"Chemokines in Vitiligo Pathogenesis: CXCL10 and 12","volume":"14","author":"Gharib","year":"2021","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lin, F., Hu, W., Xu, W., Zhou, M., and Xu, A.-E. (2021). CXCL9 as a Key Biomarker of Vitiligo Activity and Prediction of the Success of Cultured Melanocyte Transplantation. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-97296-2"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.25259\/IJDVL_793_2023","article-title":"Differential Expression of Serum CXCL9 and CXCL10 Levels in Vitiligo Patients and Their Correlation with Disease Severity and Stability: A Cross-Sectional Study","volume":"91","author":"Aulakh","year":"2025","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Speeckaert, R., Caelenberg, E.V., Belpaire, A., Speeckaert, M.M., and van Geel, N. (2024). Vitiligo: From Pathogenesis to Treatment. J. Clin. Med., 13.","DOI":"10.3390\/jcm13175225"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate Lymphocyte-Induced CXCR3B-Mediated Melanocyte Apoptosis Is a Potential Initiator of T-Cell Autoreactivity in Vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Elemam, N.M., Talaat, I.M., and Maghazachi, A.A. (2022). CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections. Viruses, 14.","DOI":"10.3390\/v14112445"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1189\/jlb.5A0717-302","article-title":"A Novel Function of CXCL10 in Mediating Monocyte Production of Proinflammatory Cytokines","volume":"102","author":"Zhao","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 Axis for Immune Activation\u2014A Target for Novel Cancer Therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"eabd8995","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-Seq of Human Vitiligo Reveals Complex Networks of Subclinical Immune Activation and a Role for CCR5 in Treg Function","volume":"13","author":"Gellatly","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jid.2016.12.028","article-title":"Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression","volume":"137","author":"Rezk","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1165\/rcmb.f318","article-title":"Chemokine Complexity: The Case for CCL5","volume":"35","author":"Grayson","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jid.2021.09.015","article-title":"Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling","volume":"142","author":"Martins","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 Axis in Human Diseases and Related Treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jid.2022.05.1090","article-title":"Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo","volume":"142","author":"Essien","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2004-03-1067","article-title":"IL-8 Responsiveness Defines a Subset of CD8 T Cells Poised to Kill","volume":"104","author":"Hess","year":"2004","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The Role of IL-17 in Vitiligo: A Review","volume":"15","author":"Singh","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00403-018-1880-2","article-title":"CXCL12 Regulates Differentiation of Human Immature Melanocyte Precursors as Well as Their Migration","volume":"311","author":"Yamada","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1097\/CM9.0000000000001689","article-title":"Pro-Pigmentary Action of 5-Fluorouracil through the Stimulated Secretion of CXCL12 by Dermal Fibroblasts","volume":"134","author":"Liao","year":"2021","journal-title":"Chin. Med. J. Engl."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative Stress Drives CD8+ T-Cell Skin Trafficking in Patients with Vitiligo through CXCL16 Upregulation by Activating the Unfolded Protein Response in Keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imr.12762","article-title":"T-Cell Positioning by Chemokines in Autoimmune Skin Diseases","volume":"289","author":"Richmond","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_88","first-page":"8796735","article-title":"The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response","volume":"2022","author":"He","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"34342","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-Type Macrophage Polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5021\/ad.2019.31.4.393","article-title":"Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata","volume":"31","author":"Zhang","year":"2019","journal-title":"Ann. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/exd.13908","article-title":"Differential Expression of Inflammatory Cytokines and Chemokines in Lipopolysaccharide-Stimulated Melanocytes from Lightly and Darkly Pigmented Skin","volume":"28","author":"Tam","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Preedy, V.R., and Patel, V.B. (2015). Macrophage Inflammatory Protein-1 Alpha (MIP-1 Alpha)\/CCL3: As a Biomarker. General Methods in Biomarker Research and Their Applications, Springer.","DOI":"10.1007\/978-94-007-7740-8_27-1"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/exd.13773","article-title":"Role of IL-17A Receptor Blocking in Melanocyte Survival: A Strategic Intervention against Vitiligo","volume":"28","author":"Bhardwaj","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/exd.12369","article-title":"T Helper 17 and T Regs: A Novel Proposed Mechanism for NB-UVB in Vitiligo","volume":"23","author":"Hegazy","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00403-019-01926-9","article-title":"Significant Reduction in the Expression of Interleukins-17A, 22 and 23A, Forkhead Box P3 and Interferon Gamma Delineates Lichen Planus Pigmentosus from Lichen Planus","volume":"311","author":"Kumaran","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Su, H.-J., Chan, Y.-P., Shen, P.-C., Ku, C.-L., and Ng, C.Y. (2022). Anti-IL-17A Antibody-Associated de Novo Vitiligo: Case Report and Review of Literature. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1077681"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e12852","DOI":"10.1111\/dth.12852","article-title":"Multiple Paradoxical Reactions During Ixekizumab Therapy","volume":"32","author":"Pirro","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/jdv.13759","article-title":"New-Onset Vitiligo and Progression of Pre-Existing Vitiligo During Treatment with Biological Agents in Chronic Inflammatory Diseases","volume":"31","author":"Bagny","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF? And the TNF Receptor Superfamily: Structure-Function Relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjd.14016","article-title":"Tumour Necrosis Factor-\u03b1 Inhibition Can Stabilize Disease in Progressive Vitiligo","volume":"173","author":"Webb","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"155432","DOI":"10.1016\/j.cyto.2021.155432","article-title":"Tumor Necrosis Factor-Alpha Affects Melanocyte Survival and Melanin Synthesis via Multiple Pathways in Vitiligo","volume":"140","author":"Singh","year":"2021","journal-title":"Cytokine"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"K\u0105dziela, M., Kutwin, M., Karp, P., and Wo\u017aniacka, A. (2024). Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications. J. Clin. Med., 13.","DOI":"10.3390\/jcm13164919"},{"key":"ref_103","first-page":"11","article-title":"The Role of Memory CD8+ T Cells in Vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cei\/uxab002","article-title":"Patho-Immunological Mechanisms of Vitiligo: The Role of the Innate and Adaptive Immunities and Environmental Stress Factors","volume":"207","author":"Faraj","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1139\/bcb-2016-0228","article-title":"Genetic Variants of Interferon-Gamma and Its mRNA Expression and Inflammatory Parameters in the Pathogenesis of Vitiligo","volume":"95","author":"Karam","year":"2017","journal-title":"Biochem. Cell Biol. Biochim. Biol. Cell."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1159\/000505544","article-title":"Association Analysis of Tumor Necrosis Factor Alpha Promoter Polymorphisms and Vitiligo Susceptibility in South Indian Tamils","volume":"236","author":"Rajendiran","year":"2020","journal-title":"Dermatol. Basel Switz."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ced.12446","article-title":"The Combination of Tumour Necrosis Factor-\u03b1 -308A and Interleukin-10 -1082G Gene Polymorphisms and Increased Serum Levels of Related Cytokines: Susceptibility to Vitiligo","volume":"40","author":"Vural","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Laddha, N.C., Dwivedi, M., and Begum, R. (2012). Increased Tumor Necrosis Factor (TNF)-\u03b1 and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility Towards Vitiligo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052298"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/jid.2013.268","article-title":"Oxidative Stress-Induced Calreticulin Expression and Translocation: New Insights into the Destruction of Melanocytes","volume":"134","author":"Zhang","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10715762.2017.1402303","article-title":"Levels of Oxidative Damage and Proinflammatory Cytokines Are Enhanced in Patients with Active Vitiligo","volume":"51","author":"Mitra","year":"2017","journal-title":"Free Radic. Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Shao, X., Chen, T., Pan, X., Chen, S., Chen, Y., and Chen, J. (2024). Biologic Drugs Induced Vitiligo: Case Reports and Review of Literature. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1455050"},{"key":"ref_112","first-page":"4120","article-title":"Possible Role of BMP-4 in the Hyper-Pigmentation of Psoriatic Plaques After Anti-TNF-\u03b1 Treatment","volume":"18","author":"Scala","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","article-title":"Levels of TGF-\u03b2(1) in Serum and Culture Supernatants of CD4(+)CD25 (+) T Cells from Patients with Non-Segmental Vitiligo","volume":"303","author":"Tu","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevImmunol.2016017480","article-title":"IL10, A Tale of an Evolutionarily Conserved Cytokine across Vertebrates","volume":"36","author":"Piazzon","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The Regulation of IL-10 Production by Immune Cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/jdv.15016","article-title":"The Role of Interleukins in Vitiligo: A Systematic Review","volume":"32","author":"Gomes","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2008.08785.x","article-title":"Gene Expression Study of IL10 Family Genes in Vitiligo Skin Biopsies, Peripheral Blood Mononuclear Cells and Sera","volume":"159","author":"Kingo","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cytogfr.2015.06.002","article-title":"The TGF-\u03b2 Superfamily in Dendritic Cell Biology","volume":"26","author":"Seeger","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1286-4579(99)00250-6","article-title":"TGF-Beta and Fibrosis","volume":"1","author":"Branton","year":"1999","journal-title":"Microbes Infect."},{"key":"ref_121","first-page":"39","article-title":"Tr1 Cells and the Counter-Regulation of Immunity: Natural Mechanisms and Therapeutic Applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Paganelli, A., Trubiani, O., Diomede, F., Pisciotta, A., and Paganelli, R. (2021). Immunomodulating Profile of Dental Mesenchymal Stromal Cells: A Comprehensive Overview. Front. Oral Health, 2.","DOI":"10.3389\/froh.2021.635055"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10753-023-01922-2","article-title":"EGR1 Mediated Reduction of Fibroblast Secreted-TGF-\u03921 Exacerbated CD8+ T Cell Inflammation and Migration in Vitiligo","volume":"47","author":"Jin","year":"2024","journal-title":"Inflammation"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/pcmr.12355","article-title":"Increased Circulating Th17 Cells and Elevated Serum Levels of TGF-beta and IL-21 Are Correlated with Human Non-segmental Vitiligo Development","volume":"28","author":"Zhou","year":"2015","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ijd.13564","article-title":"Regulatory T-cell Cytokines in Patients with Nonsegmental Vitiligo","volume":"56","author":"Kidir","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-0716-1566-9_8","article-title":"Umbrella Reviews: What They Are and Why We Need Them","volume":"Volume 2345","author":"Evangelou","year":"2022","journal-title":"Meta-Research"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdermsci.2020.06.012","article-title":"Investigating Proteome Changes between Primary and Metastatic Cutaneous Squamous Cell Carcinoma Using SWATH Mass Spectrometry","volume":"99","author":"Azimi","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Hu, Z., and Wang, T. (2023). Beyond Skin White Spots: Vitiligo and Associated Comorbidities. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1072837"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gene.2019.03.026","article-title":"CDH1 and DDR1 Common Variants Confer Risk to Vitiligo and Autoimmune Comorbidities","volume":"700","author":"Amoli","year":"2019","journal-title":"Gene"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Yao, Z., Guo, F., Tan, Y., Zhang, Y., Geng, Y., Yang, G., and Wang, S. (2024). Causal Relationship between Inflammatory Cytokines and Autoimmune Thyroid Disease: A Bidirectional Two-Sample Mendelian Randomization Analysis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1334772"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Guo, Q., Wu, Y., Hou, Y., Liu, Y., Liu, T., Zhang, H., Fan, C., Guan, H., Li, Y., and Shan, Z. (2018). Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated with Autoimmune Thyroiditis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01197"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.181089","article-title":"Endorsement of the 66\/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report","volume":"46","author":"Leung","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.12998\/wjcc.v9.i34.10430","article-title":"Association between Celiac Disease and Vitiligo: A Review of the Literature","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/2050640619874173","article-title":"Cytokine Release After Gluten Ingestion Differentiates Coeliac Disease from Self-Reported Gluten Sensitivity","volume":"8","author":"Skodje","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"eaaw7756","DOI":"10.1126\/sciadv.aaw7756","article-title":"Cytokine Release and Gastrointestinal Symptoms After Gluten Challenge in Celiac Disease","volume":"5","author":"Goel","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Ohl, K., and Tenbrock, K. (2011). Inflammatory Cytokines in Systemic Lupus Erythematosus. J. Biomed. Biotechnol., 2011.","DOI":"10.1155\/2011\/432595"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of Cytokines in Inflammatory Bowel Disease","volume":"14","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Yamaguchi, H.L., Yamaguchi, Y., and Peeva, E. (2024). Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084409"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the Significance of Cytokines and Chemokines in the Pathogenesis of Alopecia Areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel Insights into Atopic Dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/all.13954","article-title":"Interleukin-13: Targeting an Underestimated Cytokine in Atopic Dermatitis","volume":"75","author":"Bieber","year":"2020","journal-title":"Allergy"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Liu, X.-Q., Zhou, P.-L., Yin, X.-Y., Wang, A.-X., Wang, D.-H., Yang, Y., and Liu, Q. (2023). Circulating Inflammatory Cytokines and Psoriasis Risk: A Systematic Review and Meta-Analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0293327"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Brembilla, N.C., and Boehncke, W.-H. (2023). Revisiting the Interleukin 17 Family of Cytokines in Psoriasis: Pathogenesis and Potential Targets for Innovative Therapies. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1186455"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics Targeting the IL-23 and IL-17 Pathway in Psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet Lond. Engl."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/5\/684\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:42Z","timestamp":1760030382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/5\/684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":144,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["life15050684"],"URL":"https:\/\/doi.org\/10.3390\/life15050684","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}